Our study provides the identification of FoxM1 as a new STAT3 gene target and clarifies its role in proliferation, survival, drug resistance and DNA repair in chronic myeloid leukemia. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.